Oryzon Genomics S.A. (BME:ORY)
Spain flag Spain · Delayed Price · Currency is EUR
2.336
-0.010 (-0.43%)
Nov 16, 2026, 5:35 PM CET

Oryzon Genomics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-10.937.3614.1915.710.62
Revenue Growth
-48.59%-48.15%-9.60%47.88%11.49%
Cost of Revenue
0.280.280.30.240.460.75
Gross Profit
-0.2810.657.0613.9515.239.87
Selling, General & Admin
3.723.793.553.613.573.67
Other Operating Expenses
1.512.447.8614.751713.07
Operating Expenses
10.9516.3611.5618.5120.7316.88
Operating Income
-11.23-5.71-4.5-4.56-5.5-7.01
Interest Expense
-0-0-0-1.89-1.12-0.46
Interest & Investment Income
0.710.710.20.030.010.01
Currency Exchange Gain (Loss)
0.050.05-0.090.10.240.28
Other Non Operating Income (Expenses)
3.47-0.65-1.170.2-0.20
EBT Excluding Unusual Items
-6.99-5.6-5.56-6.12-6.56-7.18
Gain (Loss) on Sale of Assets
------0
Asset Writedown
-0-0----
Other Unusual Items
0.010.010.080.010.010.01
Pretax Income
-6.99-5.6-5.48-6.1-6.56-7.18
Income Tax Expense
-2.99-2.99-1.91-2.75-2.33-2.49
Net Income
-3.99-2.61-3.58-3.35-4.23-4.69
Net Income to Common
-3.99-2.61-3.58-3.35-4.23-4.69
Net Income Growth
------
Shares Outstanding (Basic)
827865615553
Shares Outstanding (Diluted)
827865615553
Shares Change
8.94%19.72%6.35%10.10%4.80%-
EPS (Basic)
-0.05-0.03-0.06-0.06-0.08-0.09
EPS (Diluted)
-0.05-0.03-0.06-0.06-0.08-0.09
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--2.42-5.79-0.57-1.92-3.8
Free Cash Flow Per Share
--0.03-0.09-0.01-0.04-0.07
Gross Margin
-97.42%95.89%98.28%97.04%92.97%
Operating Margin
--52.25%-61.18%-32.16%-35.02%-66.07%
Profit Margin
--23.83%-48.62%-23.63%-26.96%-44.15%
Free Cash Flow Margin
--22.09%-78.70%-4.05%-12.25%-35.82%
EBITDA
-11.12-5.6-4.38-4.43-5.35-6.88
EBITDA Margin
--51.19%-59.47%-31.24%-34.08%-64.81%
D&A For EBITDA
0.110.120.130.130.150.13
EBIT
-11.23-5.71-4.5-4.56-5.5-7.01
EBIT Margin
--52.25%-61.18%-32.16%-35.02%-66.07%